Initial Management of Pleural Effusion
The initial management of pleural effusion should include thoracentesis for all new and unexplained pleural effusions to determine if the effusion is transudative or exudative, with intervention indicated for symptomatic effusions regardless of size, asymptomatic effusions >400 mL, or effusions occupying >25-33% of the hemithorax on chest radiograph. 1
Diagnostic Approach
Initial Assessment
- Evaluate for symptoms: dyspnea, chest pain, cough, and tachypnea
- Classify as "clinically significant" if causing respiratory symptoms
- Note that dyspnea may be out of proportion to effusion size in pulmonary embolism 1
Imaging
- Chest radiography: First-line imaging to determine laterality and detect moderate to large effusions
- Point-of-care ultrasound: Recommended for detecting small effusions and features suggesting complicated effusion or malignancy 1, 2
- Chest CT: Consider when other causes of dyspnea need to be excluded or to evaluate for features of complicated parapneumonic or malignant effusion 2
Diagnostic Thoracentesis
- Ultrasound-guided thoracentesis is preferred over surgical tube thoracostomy 1
- Essential pleural fluid tests include:
- Biochemistry (protein, LDH)
- Cell count with differential
- Microbiology (Gram stain, culture)
- Cytology
- pH (especially important for parapneumonic effusions)
- Blood cultures should be obtained in all patients with suspected parapneumonic effusion 1
Management Algorithm
1. Transudative Effusions
- Often do not require sampling if clinical picture is clear (e.g., heart failure, cirrhosis, kidney failure) 1
- Treat the underlying medical disorder 3
- If asymptomatic: observation with follow-up imaging (chest X-ray) at 4-6 weeks 1
2. Exudative Effusions
- Require thorough investigation to determine etiology 1
- Management depends on underlying cause:
A. Parapneumonic Effusions
- If pH < 7.2: Indicates complicated parapneumonic effusion requiring:
- Prompt consultation for catheter or chest tube drainage
- Consider tissue plasminogen activator/deoxyribonuclease therapy
- Thoracoscopy may be needed in selected cases 2
- Appropriate antibiotics are essential 3
B. Malignant Effusions
- Options include:
- Therapeutic thoracentesis: For immediate symptom relief
- Chemical pleurodesis via chest tube: For symptomatic patients with good performance status and expandable lung
- Thoracoscopy with talc poudrage: For suspected but unproven malignant effusion
- Long-term indwelling pleural catheter (PleurX): For recurrent effusions, allowing outpatient management
- Pleuroperitoneal shunting: For trapped lung and large effusions refractory to pleurodesis 1
C. Other Exudative Causes
- Tuberculosis: Anti-tuberculosis therapy
- Rheumatoid/lupus effusions: Treat underlying disease
- Chylothorax: Dietary modifications, drainage procedures 4
Therapeutic Thoracentesis Guidelines
- Perform initial therapeutic thoracentesis in virtually all dyspneic patients to assess effect on symptoms 1
- Remove 1-1.5L of fluid at one sitting to avoid re-expansion pulmonary edema
- Monitor for complications: chest pain, dyspnea, and severe cough
- Ideally, monitor pleural fluid pressure during the procedure 1
Follow-up Protocol
- First follow-up within 7-10 days after initial assessment
- Telephone contact between visits for symptom monitoring
- Provide 24-hour emergency contact number for concerning symptoms
- For asymptomatic patients, schedule follow-up imaging at 4-6 weeks 1
Important Caveats
- Approximately 20% of pleural effusions remain undiagnosed despite thorough evaluation 3
- Recurrence rate after aspiration alone approaches 100% at 1 month for malignant effusions 1
- 21% of effusions may recur despite intervention 1
- Be cautious with bilateral effusions, which may not need sampling if clearly transudative 1
- For malignant effusions, early introduction of expert palliative care is recommended for symptom management 1, 5
Complications to Watch For
- Re-expansion pulmonary edema (avoid by limiting fluid removal to 1-1.5L)
- Pneumothorax
- Infection/empyema
- With indwelling catheters: local cellulitis (up to 10% of cases), infection/empyema, and tumor seeding along catheter tract 1